Microsoft is restructuring into two segments and will disclose quarterly Azure revenue starting fiscal 2027, but analyst ratings and price targets show the stock's rally predates the filing.
Inovio Pharmaceuticals (NASDAQ:INO) said its biologics license application for INO-3107, an investigational DNA medicine for recurrent respiratory papillomatosis, or RRP, remains under U.S. Food and Drug Administration review, with a target action date of Oct. 30.
President and CEO Jacqueline Shea
Check out the companies making headlines this week: Solaris Energy Infrastructure (NYSE:SEI): Mobile power and logistics company Solaris Energy Infrastructur...
Hooker Furnishings (NASDAQ:HOFT) held its second-quarter earnings conference call on Friday. Below is the complete transcript from the call. This content is powered by Benzinga APIs. For comprehensive financial data and
When someone searches for a product, service, restaurant, clinic, or professional near them, they are rarely looking just for information. They are often l
Search is no longer just about typing a few words into Google and choosing one of the first blue links. People now search through longer questions, voice c
Applied Materials supplies the tools; Intel builds the chips and factories. One is profitable and debt-light, while the other is burning cash but has a cheaper valuation.
Meta Platforms launched Muse, an autonomous AI agent with secure virtual machines and subscription options, signaling a shift from advertising toward recurring software revenue.
